The amino-acid sequence of two non-toxic mutants of diphtheria toxin: CRM45 and CRM197 - PubMed (original) (raw)
The amino-acid sequence of two non-toxic mutants of diphtheria toxin: CRM45 and CRM197
G Giannini et al. Nucleic Acids Res. 1984.
Free PMC article
Abstract
The amino-acid sequences of two diphtheria toxin-related, non-toxic proteins, CRM45 and CRM197 , were deduced from the complete sequence of their genes: tox 45 and tox 197. CRM45 lacks the last 149 C-terminal amino-acid residues, but is otherwise identical to diphtheria toxin: a single C----T transition introduces an "ochre" (TAA) termination signal in tox 45, after the codon for threonine-386. A single G----A transition was also found in tox 197, leading to the substitution of glycine-52, present in the wild-type toxin, with glutamic acid in CRM197 . This aminoacid change is responsible for the loss of the NAD:EF2 ADP-ribosyltransferase activity in CRM197 , due most probably to an alteration of the NAD+ binding site.
Similar articles
- The complete nucleotide sequence of the gene coding for diphtheria toxin in the corynephage omega (tox+) genome.
Ratti G, Rappuoli R, Giannini G. Ratti G, et al. Nucleic Acids Res. 1983 Oct 11;11(19):6589-95. doi: 10.1093/nar/11.19.6589. Nucleic Acids Res. 1983. PMID: 6314249 Free PMC article. - Cloning, sequence determination, and expression in transfected cells of the coding sequence for the tox 176 attenuated diphtheria toxin A chain.
Maxwell F, Maxwell IH, Glode LM. Maxwell F, et al. Mol Cell Biol. 1987 Apr;7(4):1576-9. doi: 10.1128/mcb.7.4.1576-1579.1987. Mol Cell Biol. 1987. PMID: 3110596 Free PMC article. - Biology and molecular epidemiology of diphtheria toxin and the tox gene.
Holmes RK. Holmes RK. J Infect Dis. 2000 Feb;181 Suppl 1:S156-67. doi: 10.1086/315554. J Infect Dis. 2000. PMID: 10657208 Review. - Diphtheria toxin cloning and expression in Corynebacterium diphtheriae.
Greenfield L. Greenfield L. Targeted Diagn Ther. 1992;7:273-305. Targeted Diagn Ther. 1992. PMID: 1633295 Review. No abstract available.
Cited by
- Serotype-specific quantification of residual free polysaccharide in multivalent pneumococcal conjugate vaccines.
Grozdanovic M, Samuel R, Grau B, Ansbro F. Grozdanovic M, et al. Glycoconj J. 2024 Feb;41(1):47-55. doi: 10.1007/s10719-023-10143-6. Epub 2024 Jan 15. Glycoconj J. 2024. PMID: 38224414 - Non-Invasive Vaccines: Challenges in Formulation and Vaccine Adjuvants.
Han S, Lee P, Choi HJ. Han S, et al. Pharmaceutics. 2023 Aug 9;15(8):2114. doi: 10.3390/pharmaceutics15082114. Pharmaceutics. 2023. PMID: 37631328 Free PMC article. Review. - Profiling Germinal Center-like B Cell Responses to Conjugate Vaccines Using Synthetic Immune Organoids.
Moeller TD, Shah SB, Lai K, Lopez-Barbosa N, Desai P, Wang W, Zhong Z, Redmond D, Singh A, DeLisa MP. Moeller TD, et al. ACS Cent Sci. 2023 Apr 12;9(4):787-804. doi: 10.1021/acscentsci.2c01473. eCollection 2023 Apr 26. ACS Cent Sci. 2023. PMID: 37122450 Free PMC article. - Monomeric crystal structure of the vaccine carrier protein CRM197 and implications for vaccine development.
Gallagher DT, Oganesyan N, Lees A. Gallagher DT, et al. Acta Crystallogr F Struct Biol Commun. 2023 Apr 1;79(Pt 4):82-86. doi: 10.1107/S2053230X23002364. Epub 2023 Mar 30. Acta Crystallogr F Struct Biol Commun. 2023. PMID: 36995122 Free PMC article. - Carriers and Antigens: New Developments in Glycoconjugate Vaccines.
van der Put RMF, Metz B, Pieters RJ. van der Put RMF, et al. Vaccines (Basel). 2023 Jan 19;11(2):219. doi: 10.3390/vaccines11020219. Vaccines (Basel). 2023. PMID: 36851097 Free PMC article. Review.
References
- J Biol Chem. 1974 Apr 10;249(7):2088-97 - PubMed
- J Biol Chem. 1973 Jun 10;248(11):3851-4 - PubMed
- Biochim Biophys Acta. 1977 Mar 28;491(1):286-95 - PubMed
- Annu Rev Biochem. 1977;46:69-94 - PubMed
- J Bacteriol. 1978 Dec;136(3):1135-42 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical